Abstract: Provided in the present invention is a 220 KV transformer movable sleeve for easy maintenance which includes a sleeve assembly and a connecting component. The sleeve assembly includes a sleeve and an end cap, and the access port is provided on the sleeve, the access port is matched with the end cap, and the connecting component includes a rotating part, a moving part and a driving part. The access port is arranged on the sleeve assembly, and the inspection can only be carried out by opening the access port during inspection, without dismantling the entire movable sleeve, and greatly improving the work efficiency. The rubber strip is combined with the metal sleeve. The method reduces the influence of magnetic flux leakage on the metal movable sleeve and prevents it from generating eddy current heating. Through the driving part, the end cap can be automatically opened, saving time and effort.

Abstract: The present invention discloses a 220 KV transformer sleeve. The sleeve includes a sleeve assembly and a connecting assembly. The sleeve assembly includes a sleeve brace, an adjustable part coupled with the sleeve brace. The connecting assembly includes a rotating part and a mobile part. The sleeve is secured on the transformer core body through screws, and the adjustable part can be opened through the connecting assembly. When maintenance is required, there is no need to dismantle the entire sleeve. The work efficiency is greatly improved. This minimizes inductance leakage and prevents eddy currents from occurring.

Abstract: The invention provides methods and compositions for treating various degenerative diseases (e.g., AMD) with a factor D inhibitor (e.g., anti-factor D antibody or antigen-binding fragment thereof). Also provided are methods of selecting or identifying patients for treatment with a factor D inhibitor. Methods include the use of prognostic and/or predictive biomarkers.

Abstract: The invention provides methods and compositions for treating various degenerative diseases (e.g., AMD) with a factor D inhibitor (e.g., anti-factor D antibody or antigen-binding fragment thereof). Also provided are methods of selecting or identifying patients for treatment with a factor D inhibitor. Methods include the use of prognostic and/or predictive biomarkers.

Abstract: Disclosed is a personal care composition comprising cooling active and copolymer comprising acrylamidopropyltrimonium chloride, wherein the weight ratio of the amount of the cooling active to the amount of the copolymer is in the range from 1:5 to 100:1. The copolymer improves deposition of the cooling active during topical application of the product to skin.

Abstract: The invention provides methods and compositions for treating various degenerative diseases (e.g., AMD) with a factor D inhibitor (e.g., anti-factor D antibody or antigen-binding fragment thereof). Also provided are methods of selecting or identifying patients for treatment with a factor D inhibitor. Methods include the use of prognostic and/or predictive biomarkers.

Abstract: The invention provides methods and compositions for treating various degenerative diseases (e.g., AMD) with a factor D inhibitor (e.g., anti-factor D antibody or antigen-binding fragment thereof). Also provided are methods of selecting or identifying patients for treatment with a factor D inhibitor. Methods include the use of prognostic and/or predictive biomarkers.

Abstract: A preparation method of a Decoy nucleic acid cationic liposome carrier including: (1) mixing dioleoyl phosphoethanolamine and (2,3-dioleoyl-propyl)-trimethylamine in a mass ratio of 4:1 to 1:4, and adding an organic solvent to obtain a mixed solution through dissolution; (2) completely evaporating the organic solvent in the mixed solution obtained in step (1), dissolving the remaining solid fraction by using an HEPES buffer solution, firstly hydrating the solution for 30 to 60 min, and then ultrasonically processing the solution for 30 to 60 min; (3) filtering the mixed system obtained after processing in the step (2) by a membrane of 0.4 to 0.8 ?m, then filtering the mixed system by a membrane of 0.03 to 0.2 ?m, and preparing uniformly to distributed blank liposome with small grain size; and (4) mixing the blank liposome with protamine and Decoy nucleic acid according to a mass ratio of (50 to 120):(10 to 20):1, and incubating for 12 to 24 h at the temperature of 2° C. to 8° C.

Abstract: Disclosed is a shampoo comprising from 1 to 15 wt % alkyl sulfate surfactant, ethoxylated alkyl sulfate surfactant or mixture thereof; from 0.5 to 12 wt % fatty acyl isethionate; and from 0.01 to 2 wt % cationic polymer, wherein the cationic polymer comprises cationic galactomannan and cationic cellulose. The shampoo is substantially free of silicone conditioning agent.

Abstract: A hair care composition is disclosed comprising cationic deposition polymer and discrete dispersed droplets of a water-insoluble conditioning agent, wherein the cationic deposition polymer comprises at least 90% by weight cationically-modified guar by weight of the cationic deposition polymer and wherein the cationically-modified guar comprises first cationically-modified guar polymer having a charge density of greater than 1.2 meq/g and a molecular weight of at least 1 million g/mol, and second cationically-modified guar polymer having a charge density of from 0.8 to 1.2 meq/g and a molecular weight of at least 1 million g/mol.

Abstract: Disclosed is a personal care composition comprising cooling active and copolymer comprising acrylamidopropyltrimonium chloride, wherein the weight ratio of the amount of the cooling active to the amount of the copolymer is in the range from 1:5 to 100:1. The copolymer improves deposition of the cooling active during topical application of the product to skin.

Abstract: The invention provides methods and compositions for treating various degenerative diseases (e.g., AMD) with a factor D inhibitor (e.g., anti-factor D antibody or antigen-binding fragment thereof). Also provided are methods of selecting or identifying patients for treatment with a factor D inhibitor. Methods include the use of prognostic and/or predictive biomarkers.

Abstract: A method is provided herein for determining and recognizing types of vehicles passing a check point. The method takes advantage of an EM algorithm which is up-loaded into a CPU and which processes data of the vehicles which drive past a checkpoint, the data being representative of essential characteristics of vehicles to produce an output model of the traffic volumes of the various types of vehicles. This model enables the forecasting of future road maintenance costs and the planning and designing of future road networks.

Abstract: A feedback control circuit for a power converter and a power converter system, includes a sampling network, configured to sample an input or output of the power converter, and output a first sampled signal; a filtering network, configured to receive the first sampled signal and output a second sampled signal, the filtering network filtering a ripple signal at a preset frequency out from the first sampled signal, so as to remain signals therein outside the preset frequency, while maintaining a phase delay between the second sampled signal and the first sampled signal within a preset range; a control and drive circuit, configured to receive the second sampled signal, and regulate in accordance with the second sampled signal a control signal outputted from the control and drive circuit to the power converter.

Abstract: A method is provided herein for determining and recognizing types of vehicles passing a check point. The method takes advantage of an EM algorithm which is up-loaded into a CPU and which processes data of the vehicles which drive past a checkpoint, the data being representative of essential characteristics of vehicles to produce an output model of the traffic volumes of the various types of vehicles.

Abstract: Systems and methods that determine resonant frequencies of a motor system via employing an output of a velocity regulator. The velocity regulator enables the motor drive to command the rotation of the motor at predetermined rotations, by setting rotational speeds of the motor. The output of the velocity regulator can then be stored as a function of time, and a Fast Fourier Transform performed on such time data to obtain a frequency data and a signal power spectrum.

Abstract: Systems and methods that determine resonant frequencies of a motor system via employing an output of a velocity regulator. The velocity regulator enables the motor drive to command the rotation of the motor at predetermined rotations, by setting rotational speeds of the motor. The output of the velocity regulator can then be stored as a function of time, and a Fast Fourier Transform performed on such time data to obtain a frequency data and a signal power spectrum.